Researchers identify patient response patterns to novel schizophrenia medication
View as a Web Page
News Medical
 
  Schizophrenia Schizophrenia logo  
  The latest schizophrenia news from News Medical  
 Breakthrough study identifies potential treatment for schizophrenia symptomsBreakthrough study identifies potential treatment for schizophrenia symptoms
 
Difficulty completing everyday tasks. Failing memory. Unusually poor concentration.		 
 
 Researchers identify patient response patterns to novel schizophrenia medicationResearchers identify patient response patterns to novel schizophrenia medication
 
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality.		 
   Shared genetic roots connect neurological and psychiatric disordersShared genetic roots connect neurological and psychiatric disorders
 
In a groundbreaking study, researchers from the Centre for Precision Psychiatry at the University of Oslo and Oslo University Hospital have discovered extensive genetic links between neurological disorders like migraine, stroke and epilepsy, and psychiatric illnesses such as schizophrenia and depression.		 
   Commonly prescribed antibiotic linked to lower risk of schizophreniaCommonly prescribed antibiotic linked to lower risk of schizophrenia
 
A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research suggests.		 
   New computer model lets researchers simulate how brain circuits make decisionsNew computer model lets researchers simulate how brain circuits make decisions
 
Every day, your brain makes thousands of decisions under uncertainty. Most of the time, you guess right. When you don't, you learn. But when the brain's ability to judge context or assign meaning falters, thoughts and behavior can go astray.		 
 Low-cost biosensor identifies altered protein levels associated with psychiatric disorders
 
Low-cost biosensor identifies altered protein levels associated with psychiatric disordersBrazilian researchers have developed a low-cost, portable biosensor that can quickly identify a protein whose altered levels are associated with psychiatric disorders, such as depression, schizophrenia, and bipolar disorder.		 
 
 Schizophrenia risk detectable at birth through epigenetic signatures
 
Genetic susceptibility to neurodevelopmental conditions such as schizophrenia, autism, and ADHD can be linked, in part, to distinct epigenetic signatures in newborn cord blood.		 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025